Advertisement

Topics

Psoriasis drug also effective at reducing aortic inflammation

18:44 EST 18 Feb 2018 | News-Medical.net

Ustekinumab, sold under the name Stelara, is approved by the U.S. Food and Drug Administration to treat psoriasis, psoriatic arthritis, and Crohn's Disease. Researchers wanted to know if the benefits of the drug go beyond clearing the skin.

Original Article: Psoriasis drug also effective at reducing aortic inflammation

NEXT ARTICLE

More From BioPortfolio on "Psoriasis drug also effective at reducing aortic inflammation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...